T. Rowe Price Associates
SGHT icon

T. Rowe Price Associates’s Sight Sciences SGHT Stock Holding History

T. Rowe Price Associates’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Buy
32,294
+7,011
+28% +$32.3K ﹤0.01% 3045
2026
Q1 		$96K Hold
25,283
– – ﹤0.01% 3010
2025
Q4 		$201K Buy
25,283
+4,498
+22% +$28.7K ﹤0.01% 2810
2025
Q3 		$72K Buy
20,785
+1,778
+9% +$6.62K ﹤0.01% 2975
2025
Q2 		$79K Buy
19,007
+5,251
+38% +$17.5K ﹤0.01% 2936
2025
Q1 		$34K Hold
13,756
– – ﹤0.01% 2971
2024
Q4 		$51K Buy
13,756
+2,485
+22% +$11.3K ﹤0.01% 2941
2024
Q3 		$72K Hold
11,271
– – ﹤0.01% 2877
2024
Q2 		$76K Buy
+11,271
New +$66.6K ﹤0.01% 2790

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

T. Rowe Price Associates's SGHT Position: Q2 2026 in Review

T. Rowe Price Associates increased its Sight Sciences (SGHT) stake by 28% in Q2 2026, buying an estimated $32.3K and bringing the position to 32,294 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #3045.

T. Rowe Price Associates first reported a position in SGHT in Q2 2024 and has held it in 9 quarters since. The position peaked at $201K in Q4 2025. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • T. Rowe Price Associates held 32,294 shares of Sight Sciences worth $176K as of Q2 2026.
  • T. Rowe Price Associates bought 7,011 Sight Sciences shares in Q2 2026, an estimated $32.3K.
  • Sight Sciences made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3045 holding.
  • T. Rowe Price Associates first reported a position in Sight Sciences in Q2 2024 and has held it in 9 quarters since.
  • T. Rowe Price Associates's Sight Sciences position peaked at $201K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.